Immunotoxicology Laboratory, Toxicology and Biomedicine Center (TOXIMED), Medical Science University, Autopista Nacional Km. 1 1/2, CP 90400 Santiago de Cuba, Cuba; Faculty of Pharmaceutical Sciences, Universidade Estadual Paulista Julio Mesquita Filho (UNESP), Rua Expedicionarios do Brasil 1621, CEP 14801-902 Araraquara, SP, Brazil; CAPES-PVE/Brasil Grant, Foreigner Visiting Professor Program, Brazil.
Faculty of Pharmaceutical Sciences, Universidade Estadual Paulista Julio Mesquita Filho (UNESP), Rua Expedicionarios do Brasil 1621, CEP 14801-902 Araraquara, SP, Brazil.
Int Immunopharmacol. 2014 May;20(1):170-80. doi: 10.1016/j.intimp.2014.02.033. Epub 2014 Mar 6.
Vaccine safety is a topic of concern for the treated individual, the family, the health care personnel, and the others involved in vaccination programs as recipients or providers. Adjuvants are necessary components to warrant the efficacy of vaccines, however the overstimulation of the immune system is also associated with adverse effects. Local reactions are the most frequent manifestation of toxicity induced by adjuvanted vaccines and, with the exception of the acute phase response (APR), much less is known about the systemic reactions that follow vaccination. Their low frequency or subclinical expression meant that this matter has been neglected. In this review, various systemic reactions associated with immune stimulation will be addressed, including: APR, hypersensitivity, induction or worsening of autoimmune diseases, modification of hepatic metabolism and vascular leak syndrome (VLS), with an emphasis on the mechanism involved. Finally, the authors analyze the current focus of discussion about vaccine safety and opportunities to improve the design of new adjuvanted vaccines in the future.
疫苗安全性是接受治疗的个体、家庭、医护人员以及疫苗接种计划的其他参与者关注的话题,因为他们可能是疫苗的接受者或提供者。佐剂是保证疫苗疗效的必要组成部分,但是免疫系统的过度刺激也与不良反应有关。局部反应是佐剂疫苗引起的毒性最常见的表现形式,除了急性期反应 (APR) 之外,人们对疫苗接种后发生的全身反应知之甚少。由于这些反应的频率较低或表现为亚临床状态,因此这方面的问题被忽视了。在这篇综述中,将讨论与免疫刺激相关的各种全身反应,包括 APR、过敏反应、自身免疫性疾病的诱导或恶化、肝代谢改变和血管渗漏综合征 (VLS),并重点介绍相关的作用机制。最后,作者分析了当前关于疫苗安全性的讨论重点以及未来改进新型佐剂疫苗设计的机会。